SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-16-541449
Filing Date
2016-04-14
Accepted
2016-04-14 16:26:01
Documents
53
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q AMENDMENT NO. 1 d179909d10qa.htm 10-Q/A 265498
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER d179909dex311.htm EX-31.1 8638
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER d179909dex321.htm EX-32.1 3355
  Complete submission text file 0001193125-16-541449.txt   2370610

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT tpiv-20150331.xml EX-101.INS 426125
5 XBRL TAXONOMY EXTENSION SCHEMA tpiv-20150331.xsd EX-101.SCH 35812
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tpiv-20150331_cal.xml EX-101.CAL 33498
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tpiv-20150331_def.xml EX-101.DEF 105351
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tpiv-20150331_lab.xml EX-101.LAB 214629
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tpiv-20150331_pre.xml EX-101.PRE 189231
Mailing Address 50 N LAURA STREET SUITE 2500 JACKSONVILLE FL 98102
Business Address 50 N LAURA STREET SUITE 2500 JACKSONVILLE FL 98102 (206) 504-7278
TAPIMMUNE INC (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: NV | Fiscal Year End: 0220
Type: 10-Q/A | Act: 34 | File No.: 000-27239 | Film No.: 161572021
SIC: 2834 Pharmaceutical Preparations